TB Alliance | 6 hours ago
TB Alliance, a non-profit organization dedicated to developing better and faster cures for tuberculosis (TB), today announced a unique collaboration with food and beverage company PepsiCo designed to improve the treatment for children with TB. Many of today’s TB treatments are very bitter or unpleasant in taste, which when compounded with the long duration of treatment for TB, can lead to low tolerance and poor compliance – especially among children.
Access to medicines and treatment
World Health Organization | 27 October 2016
Over one million people in low- and middle-income countries have been treated with a revolutionary new cure for hepatitis C since its introduction two years ago.
Health monitoring in resource-limited settings
The Conversation | 27 October 2016
An essential diagnostics list would detail diagnostic tests that should be available to people who need them. These could range from point-of-care tests in physicians’ offices or in pharmacies to high-complexity tests in reference laboratories. The end result would be a health system where people were more accurately diagnosed and treated, where disease outbreaks could be identified earlier, and diagnostic tests performed according to a high standard.
Tuberculosis and HIV
Health-e | 27 October 2016
Exposure to infectious patients, high HIV rates and a lack of ventilation in facilities are some of the reasons healthcare workers in South Africa have the one of the highest tuberculosis (TB) infection rates in the world.
Project Inform | 27 October 2016
It is an open question whether generic competition in the United States, at least in the short term, will actually materialize or if it does, lead to reduced prices. If savings are realized, there is also no guarantee they will be funneled back into other critical HIV services.
Global health initiatives
Sexuality Policy Watch | 27 October 2016
This timely book, authored by Hakan Seckinelgin (London School of Economics and Political Science), looks critically at the policy response to AIDS and its institutionalization over time. It raises important questions about who benefits, who decides, and in whose interests decisions are made.
Science Speaks | 27 October 2016
Presentations this morning highlighted efforts to reach female sex workers with data from studies in South Africa, Rwanda and Kenya that provided HIV self-testing, antiretroviral treatment, pre-exposure prophylactic use of antiretroviral drugs — PrEP — and other services.
Science Speaks | 26 October 2016
Presenting results today of a nine month treatment regimen that led to an 82 percent cure rate among 1006 patients with multidrug-resistant tuberculosis, researchers called their findings a breakthrough that can support countries in adopting shorter, more effective and potentially less damaging treatment for TB that is resistant to more than one first line treatment.
History of HIV and AIDS
BBC Health | 26 October 2016
One of the most demonised patients in history - Gaetan Dugas - has been convincingly cleared of reports he spread HIV to the US, say scientists.
Science Speaks | 26 October 2016
Even before the costs of getting diagnosed, picked up in some high-tuberculosis incidence countries by patients themselves, and even before treatment brings its own costs, the financial toll of tuberculosis has already begun, a representative of the World Health Organization said today.